Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial

Felix C. Ringshausen*, Adam J. Shapiro, Kim G. Nielsen, Henryk Mazurek, Massimo Pifferi, Karl H. Donn, Menno M. van der Eerden, Michael R. Loebinger, Maimoona A. Zariwala, Margaret W. Leigh, Michael R. Knowles, Thomas W. Ferkol, CLEAN-PCD investigators and study team

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial'. Together they form a unique fingerprint.

Neuroscience

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science